The head of the Axencia Galega de Innovación of the Consellería de Educación, Ciencia, Universidades e FP, Carmen Cotelo, visited Diversa Technologies this morning. The company is a spin-off from the Fundación Instituto de Investigación Sanitaria de Santiago de Compostela and the Sergas, and is one of the six beneficiaries of the Xunta's 2025 Neotec Excellence Recovery call.
During the visit, Cotelo had the opportunity to learn firsthand about the project to develop lipid nanosystems for the transport and intracellular release of nucleic acids for gene therapy in rare diseases. The initiative is being driven under the Neotec program with co-financing from European funds from the Galicia Feder 2021-2027 program.
The biotechnology company, which emerged with the support of the Xunta de Galicia's Ignicia program, possesses proprietary technology for transporting drugs to hard-to-reach targets. It has also defined its business model and attracted the interest of national and international distributors and investors, in addition to receiving numerous awards for innovative entrepreneurship.
The objective of the Xunta's Neotec Excellence Recovery program is to support Galician companies developing innovative solutions with high market potential that did not secure funding in the state Neotec call due to insufficient credit, thereby enabling their viability and growth.




